Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers.
Saved in:
| Title: | Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers. |
|---|---|
| Authors: | Nyanhete TE; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Immunology, Duke University School of Medicine, Durham, NC, United States., Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Medicine, Duke University School of Medicine, Durham, NC, United States., LaBranche CC; Department of Surgery, Duke University School of Medicine, Durham, NC, United States., Mansouri K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Eaton A; Department of Surgery, Duke University School of Medicine, Durham, NC, United States., Dennison SM; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University School of Medicine, Durham, NC, United States., Saunders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University School of Medicine, Durham, NC, United States., Goodman D; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University School of Medicine, Durham, NC, United States., Janowska K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Spreng RL; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Medicine, Duke University School of Medicine, Durham, NC, United States., Zhang L; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University School of Medicine, Durham, NC, United States., Mudrak SV; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University School of Medicine, Durham, NC, United States., Hope TJ; Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States., Hora B; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Medicine, Duke University School of Medicine, Durham, NC, United States., Bradley T; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Medicine, Duke University School of Medicine, Durham, NC, United States., Georgiev IS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, United States., Montefiori DC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University School of Medicine, Durham, NC, United States., Acharya P; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University School of Medicine, Durham, NC, United States., Tomaras GD; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Immunology, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University School of Medicine, Durham, NC, United States.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2021 Dec 23; Vol. 12, pp. 670561. Date of Electronic Publication: 2021 Dec 23 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2021.670561 |
